We, therefore, reasoned that PPM1D truncations associated with PPM1D-mutant gliomas may also exhibit the enhanced activity of the PPM1D phosphatase, targeting known substrates in the DDR and cell cycle pathways. The gene discussed is PPM1D; the disease is glioma.